塔科苏博综合征中的微RNA:压力诱导心肌病调节网络的系统审查
Domingos Sousa1,2,3, Filipa Abreu Martins1,4, Ângelo Luís1,5
1RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
International journal of molecular sciences
|October 16, 2025
概括
微RNA (miRNA) 是基因调节和心血管疾病的关键. 本综述探讨了它们在塔科苏博综合征 (TTS) 中的作用,建议miRNAs作为这种疾病的潜在生物标志物和治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 遗传学 是一个遗传学.
背景情况:
- 微RNAs (miRNAs) 是基因表达的关键调节者.
- 它们在包括心血管疾病在内的生理和病理过程中起着重要作用.
- 塔科茨博综合征 (TTS) 是一种具有复杂病理生理学的疾病.
研究的目的:
- 系统地审查有关miRNAs参与塔科苏博综合征 (TTS) 的现有证据.
- 探索miRNAs作为TTS生物标志物或治疗点的潜力.
- 提供心血管病理生理学中miRNAs的概述,重点关注TTS.
主要方法:
- 在遵守PRISMA指南的基础上进行系统审查.
- 在PubMed,Web of Science和Scopus数据库中进行了搜索.
- 从584个初始记录中,包括了14篇全文文章用于定性分析.
主要成果:
- 多个miRNA与TTS病理生理学有关.
- 这些miRNAs参与心肌炎症,氧化应激,亡和心脏重塑.
- 审查的研究强调了miRNAs和TTS之间的复杂相互作用.
结论:
- miRNAs在Takotsubo综合征背后的病理过程中起着重要作用.
- miRNAs代表了未来诊断生物标志物和TTS治疗策略的有希望的途径.
- 这是对TTS中的miRNAs的首次系统性探索,提供了新的见解.
相关概念视频
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
351
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
351
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
449
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
449
01:26Coronary Artery Disease II: Pathophysiology
366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366
01:25Cardiomyopathy I: Introduction and Classification
498
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
498
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
399
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
399
01:30Acute Coronary Syndrome III: Diagnostic Studies
209
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
209